Evidence map›Paper›PMID 37491339›Full record

ArticleOncogenesis2023

Correction: Targeting IL-3Rα on tumor-derived endothelial cells blunts metastatic spread of triple-negative breast cancer via extracellular vesicle reprogramming.

Tatiana Lopatina, Cristina Grange, Claudia Cavallari, Victor Navarro-Tableros, Giusy Lombardo, Arturo Rosso, Massimo Cedrino, Margherita Alba Carlotta Pomatto, Malvina Koni, Francesca Veneziano and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncogenesis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Tatiana Lopatina *Department of Medical Sciences, University of Turin, Turin, Italy.
Cristina Grange *Department of Medical Sciences, University of Turin, Turin, Italy.
Claudia Cavallari2i3T Scarl University of Turin, Turin, Italy.
Victor Navarro-Tableros2i3T Scarl University of Turin, Turin, Italy.
Giusy LombardoDepartment of Medical Sciences, University of Turin, Turin, Italy.
Arturo RossoDepartment of Medical Sciences, University of Turin, Turin, Italy.
Massimo Cedrino2i3T Scarl University of Turin, Turin, Italy.
Margherita Alba Carlotta PomattoDepartment of Medical Sciences, University of Turin, Turin, Italy.
Malvina KoniDepartment of Medical Sciences, University of Turin, Turin, Italy.
Francesca VenezianoDepartment of Medical Sciences, University of Turin, Turin, Italy.
Isabella CastellanoDepartment of Medical Sciences, University of Turin, Turin, Italy.
Giovanni CamussiDepartment of Medical Sciences, University of Turin, Turin, Italy.
Maria Felice BrizziDepartment of Medical Sciences, University of Turin, Turin, Italy. mariafelice.brizzi@unito.it.ORCID http://orcid.org/0000-0003-0944-6992

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37491339
PMCPMC10368711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.